102 related articles for article (PubMed ID: 3166079)
1. DNA, RNA, and protein content in adult acute myeloid leukemia: effects of cytostatic drugs in vivo.
Wolowiec D; Ffrench M; Tigaud JD; Treille-Ritouet D; Archimbaud E; Bryon PA
Leukemia; 1988 Aug; 2(8):534-9. PubMed ID: 3166079
[TBL] [Abstract][Full Text] [Related]
2. Cell-cycle, protein content, and nuclear size in acute myeloid leukemia.
Ffrench M; Bryon PA; Fiere D; Vu Van H; Gentilhomme O; Adeleine P; Viala JJ
Cytometry; 1985 Jan; 6(1):47-53. PubMed ID: 3855395
[TBL] [Abstract][Full Text] [Related]
3. [Simultaneous determination of cellular DNA and proteins by cytofluorimetry. Application to acute leukemia in adults].
Ffrench M; Fiere D; Bryon PA; Cordier G; Viala JJ
Pathol Biol (Paris); 1984 Feb; 32(2):139-43. PubMed ID: 6366709
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
5. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hematologic malignancies by flow cytometry.
Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
8. Quantitative cytology in leukemia research.
Barlogie B; Maddox AM; Johnston DA; Raber MN; Drewinko B; Keating MJ; Freireich EJ
Blood Cells; 1983; 9(1):35-55. PubMed ID: 6344934
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.
Powell BL; Kute TE; Craig JB; Lyerly ES; Gregory BW; Do KA; Contento MM; Capizzi RL
Leukemia; 1990 May; 4(5):316-20. PubMed ID: 2388477
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
11. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
12. DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy.
Maddox AM; Johnston DA; Barlogie B; Youness E; Keating M; Freireich EJ
J Clin Oncol; 1985 Jun; 3(6):799-808. PubMed ID: 4009216
[TBL] [Abstract][Full Text] [Related]
13. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
14. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
Riccardi A; Montecucco CM; Danova M; Ucci G; Mazzini G; Giordano PA; Pasquali F
Basic Appl Histochem; 1986; 30(2):181-92. PubMed ID: 2427061
[TBL] [Abstract][Full Text] [Related]
16. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
[TBL] [Abstract][Full Text] [Related]
17. Recognition of central nervous system leukemia by flow cytometry.
Redner A; Andreeff M; Miller DR; Steinherz P; Melamed M
Cytometry; 1984 Nov; 5(6):614-8. PubMed ID: 6596184
[TBL] [Abstract][Full Text] [Related]
18. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of cellular DNA-RNA content using flow cytometry between primary and metastatic foci in lung carcinoma].
Yamaoka N; Tagawa Y; Ayabe H; Kawahara K; Kida H; Uchiyama T; Tomita M
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):901-6. PubMed ID: 2169021
[TBL] [Abstract][Full Text] [Related]
20. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
Wongprajun S; Auewarakul CU
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
